A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma☆-Reference-Cited by-同舟云学术

A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma☆

Published:2021-04 Issue:2 Volume:6 Page:100050
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Tarhini A.A.^ORCID,Toor K.,Chan K.,McDermott D.F.,Mohr P.,Larkin J.,Hodi F.S.,Lee C.-H.,Rizzo J.I.,Johnson H.,Moshyk A.,Rao S.,Kotapati S.,Atkins M.B.

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Systematic review of medical treatment in melanoma: current status and future prospects;Garbe;Oncologist,2011

2. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

3. Long-term outcomes in BRAF-mutated melanoma treated with combined targeted therapy or immune checkpoint blockade: are we approaching a true cure?;Schummer;Am J Clin Dermatol,2020

4. Current melanoma treatments: where do we stand?;Moreira;Cancers (Basel),2021

5. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

2. Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression;British Journal of Dermatology;2024-01-10

3. Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-β activity and CD8⁺ T-cell infiltration in breast cancer;Theranostics;2024

4. Cancer-associated Fibroblast Spatial Heterogeneity andEMILIN1Expression in Cancer Stroma Modulate TGF-β Activity and CD8⁺T-Cell Infiltration in Breast Cancer;2023-09-15

5. Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study);Cancer Medicine;2023-08-16